Behavioral Health Initial Intake Outreach
A Randomized Controlled Trial of Patient Messages Before Behavioral Health Intake Calls to Increase Group Psychotherapy Uptake
1 other identifier
interventional
6,200
1 country
1
Brief Summary
The goal of this study is to help patients get seen sooner for behavioral health appointments by informing them about group therapy options, which allow more patients to be seen at once, often more quickly than 1:1 therapy. We will test whether messages describing the benefits of group therapy might encourage more patients to sign up for group therapy, thereby shortening patients' time to beginning therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2026
CompletedFirst Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
August 27, 2026
August 1, 2026
1.5 years
August 24, 2026
August 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to first psychotherapy appointment
Time from the date the intervention message is sent (or the corresponding index date for patients assigned to usual care) to the patient's first completed psychotherapy appointment, whether group or 1:1
Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)
Other Outcomes (9)
Time to first group psychotherapy appointment
Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)
Time to first 1:1 psychotherapy appointment
Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)
Completion of psychotherapy appointment (y/n)
Within 6 months after the intervention message is sent (or the corresponding index date for patients assigned to usual care)
- +6 more other outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONPatients will receive usual care and will not receive the pre-intake call informational messages. Usual care includes the standard scheduling and communication processes for behavioral health intake appointments.
Pre-Intake Appointment Messages
EXPERIMENTALPatients will receive informational messages delivered through MyChart or text message before their scheduled behavioral health intake appointment. Patient instructions will also be modified.
Interventions
Informational messages delivered through MyChart or text message before a scheduled behavioral health intake call. The MyChart messages explain that the intake call is a one-time appointment to determine the most appropriate treatment plan, describe potential benefits of group psychotherapy, and provide a link to additional educational information about group therapy. Patient instructions with the same information added to the appointment within MyChart. Patients who do not have MyChart but can be sent text messages will get brief text messages with a link to MyChart to view patient instructions with information about group therapy.
Eligibility Criteria
You may qualify if:
- Patient is age 18 years or older
- Patient is referred for outpatient behavioral health psychotherapy services at Geisinger
- Patient has a scheduled behavioral health intake appointment
- Patient is eligible to receive pre-appointment messages through MyChart and/or SMS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geisinger Cliniclead
Study Sites (1)
Geisinger Clinic
Danville, Pennsylvania, 17822, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Gail Rosenbaum, PhD
Geisinger Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Patients are assigned to the intervention arm will be aware of the message and visit instructions, but they will not know that some patients do not get the message and visit instructions.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Program Director, Geisinger Behavioral Insights Team
Study Record Dates
First Submitted
August 24, 2026
First Posted
August 27, 2026
Study Start
August 20, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share